BackBCWORLD PHARM. , Ltd. Overview

BCWORLD PHARM. , Ltd. Receivables

Latest receivables for 200780.KQ: $19B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$19.49B
↑ 4.14% YoYΔ $775.23M vs prior year quarter

Peer trimmed avg / median

Loading

BCWORLD PHARM. , Ltd. Receivables History

Loading

BCWORLD PHARM. , Ltd. vs. peers: Receivables Comparison

Loading

BCWORLD PHARM. , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BCWORLD PHARM. , Ltd. (200780.KQ) FAQ

As of the most recent data (June 2026), 200780.KQ shows a receivables of $19B. That compares with $19B in the prior-year period — up 4.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 200780.KQ's receivables is now $19B (was $19B) — a 4.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BCWORLD PHARM. , Ltd. is outperforming or lagging.

Tracking 200780.KQ's receivables over time shows whether BCWORLD PHARM. , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $19B That compares with $19B in the prior-year period — up 4.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has BCWORLD PHARM. , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $19B) with ownership activity and broader fundamentals.